GE HealthCare Technologies Inc. (NASDAQ: GEHCV) Stock Competitors & Peer Comparison
See GEHCV's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for GEHCV and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $58.40 | -1.23% | 11.5B | 47.10 | $1.24 | N/A |
| BTSGU | $192.60 | -4.74% | 11.3B | 174.16 | $1.11 | N/A |
| TEM | $63.05 | -1.55% | 11B | -126.10 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $96.54 | +0.18% | 8.1B | 22.56 | $4.28 | N/A |
| TXG | $62.45 | +1.48% | 7.9B | -105.85 | -$0.59 | N/A |
| HNGE | $92.56 | +5.96% | 7.2B | 49.55 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| WAY | $26.18 | -0.23% | 5B | 17.34 | $1.51 | N/A |
Stock Comparison
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
GEHCV vs BTSG Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, BTSG has a market cap of 11.5B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while BTSG trades at $58.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas BTSG's P/E ratio is 47.10. In terms of profitability, GEHCV's ROE is +0.19%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, GEHCV is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
GEHCV vs BTSGU Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, BTSGU has a market cap of 11.3B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while BTSGU trades at $192.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas BTSGU's P/E ratio is 174.16. In terms of profitability, GEHCV's ROE is +0.19%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, GEHCV is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
GEHCV vs TEM Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, TEM has a market cap of 11B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while TEM trades at $63.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas TEM's P/E ratio is -126.10. In terms of profitability, GEHCV's ROE is +0.19%, compared to TEM's ROE of -0.55%. Regarding short-term risk, GEHCV is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
GEHCV vs SGFY Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SGFY's P/E ratio is 70.91. In terms of profitability, GEHCV's ROE is +0.19%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, GEHCV is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
GEHCV vs HQY Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, HQY has a market cap of 8.1B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while HQY trades at $96.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas HQY's P/E ratio is 22.56. In terms of profitability, GEHCV's ROE is +0.19%, compared to HQY's ROE of +0.11%. Regarding short-term risk, GEHCV is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
GEHCV vs TXG Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, TXG has a market cap of 7.9B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while TXG trades at $62.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas TXG's P/E ratio is -105.85. In terms of profitability, GEHCV's ROE is +0.19%, compared to TXG's ROE of -0.09%. Regarding short-term risk, GEHCV is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
GEHCV vs HNGE Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, HNGE has a market cap of 7.2B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while HNGE trades at $92.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas HNGE's P/E ratio is 49.55. In terms of profitability, GEHCV's ROE is +0.19%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, GEHCV is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
GEHCV vs RCM Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas RCM's P/E ratio is -102.21. In terms of profitability, GEHCV's ROE is +0.19%, compared to RCM's ROE of +0.00%. Regarding short-term risk, GEHCV is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check RCM's competition here
Waystar Holding Corp. (NASDAQ: WAY)
GEHCV vs WAY Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, WAY has a market cap of 5B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while WAY trades at $26.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas WAY's P/E ratio is 17.34. In terms of profitability, GEHCV's ROE is +0.19%, compared to WAY's ROE of +0.04%. Regarding short-term risk, GEHCV is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check WAY's competition here
Doximity, Inc. (NYSE: DOCS)
GEHCV vs DOCS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, DOCS has a market cap of 5B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while DOCS trades at $26.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas DOCS's P/E ratio is 17.45. In terms of profitability, GEHCV's ROE is +0.19%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, GEHCV is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check DOCS's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
GEHCV vs HTFL Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, HTFL has a market cap of 4.3B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while HTFL trades at $50.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas HTFL's P/E ratio is -25.07. In terms of profitability, GEHCV's ROE is +0.19%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, GEHCV is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
GEHCV vs ONEM Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ONEM's P/E ratio is -7.77. In terms of profitability, GEHCV's ROE is +0.19%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, GEHCV is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
GEHCV vs PRVA Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, PRVA has a market cap of 2.6B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while PRVA trades at $20.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas PRVA's P/E ratio is 97.57. In terms of profitability, GEHCV's ROE is +0.19%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, GEHCV is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check PRVA's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
GEHCV vs NXGN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas NXGN's P/E ratio is -266.00. In terms of profitability, GEHCV's ROE is +0.19%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, GEHCV is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check NXGN's competition here
Omnicell, Inc. (NASDAQ: OMCL)
GEHCV vs OMCL Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, OMCL has a market cap of 1.6B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while OMCL trades at $35.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas OMCL's P/E ratio is 18.41. In terms of profitability, GEHCV's ROE is +0.19%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, GEHCV is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check OMCL's competition here
Omada Health (NASDAQ: OMDA)
GEHCV vs OMDA Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, OMDA has a market cap of 1.5B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while OMDA trades at $24.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas OMDA's P/E ratio is 350.71. In terms of profitability, GEHCV's ROE is +0.19%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, GEHCV is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
GEHCV vs AGTI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas AGTI's P/E ratio is -71.79. In terms of profitability, GEHCV's ROE is +0.19%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, GEHCV is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check AGTI's competition here
Certara, Inc. (NASDAQ: CERT)
GEHCV vs CERT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CERT trades at $8.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CERT's P/E ratio is 20.73. In terms of profitability, GEHCV's ROE is +0.19%, compared to CERT's ROE of -0.07%. Regarding short-term risk, GEHCV is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
GEHCV vs GDRX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while GDRX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas GDRX's P/E ratio is 10.91. In terms of profitability, GEHCV's ROE is +0.19%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, GEHCV is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check GDRX's competition here
Teladoc Health, Inc. (NYSE: TDOC)
GEHCV vs TDOC Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while TDOC trades at $6.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas TDOC's P/E ratio is -6.39. In terms of profitability, GEHCV's ROE is +0.19%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, GEHCV is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check TDOC's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
GEHCV vs CCLDO Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CCLDO's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, GEHCV is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
GEHCV vs HSTM Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, HSTM has a market cap of 848.7M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while HSTM trades at $29.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas HSTM's P/E ratio is 40.35. In terms of profitability, GEHCV's ROE is +0.19%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, GEHCV is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check HSTM's competition here
Phreesia, Inc. (NYSE: PHR)
GEHCV vs PHR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, PHR has a market cap of 754.7M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while PHR trades at $12.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas PHR's P/E ratio is 43.61. In terms of profitability, GEHCV's ROE is +0.19%, compared to PHR's ROE of +0.03%. Regarding short-term risk, GEHCV is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check PHR's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
GEHCV vs SOPH Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SOPH has a market cap of 704.7M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SOPH trades at $8.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SOPH's P/E ratio is -7.57. In terms of profitability, GEHCV's ROE is +0.19%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, GEHCV is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SOPH's competition here
Claritev Corporation (NYSE: CTEV)
GEHCV vs CTEV Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CTEV has a market cap of 676.8M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CTEV trades at $39.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CTEV's P/E ratio is -2.33. In terms of profitability, GEHCV's ROE is +0.19%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, GEHCV is more volatile compared to CTEV. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CTEV's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
GEHCV vs MPLN-WT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, GEHCV is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
GEHCV vs ACCD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ACCD's P/E ratio is -3.08. In terms of profitability, GEHCV's ROE is +0.19%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, GEHCV is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
GEHCV vs SHCR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SHCR's P/E ratio is -3.76. In terms of profitability, GEHCV's ROE is +0.19%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, GEHCV is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
GEHCV vs EVH Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, EVH has a market cap of 505.6M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while EVH trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas EVH's P/E ratio is 34.58. In terms of profitability, GEHCV's ROE is +0.19%, compared to EVH's ROE of -0.99%. Regarding short-term risk, GEHCV is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check EVH's competition here
NRC Health (NASDAQ: NRC)
GEHCV vs NRC Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, NRC has a market cap of 471.9M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while NRC trades at $20.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas NRC's P/E ratio is 25.54. In terms of profitability, GEHCV's ROE is +0.19%, compared to NRC's ROE of +0.48%. Regarding short-term risk, GEHCV is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
GEHCV vs SLGC Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SLGC's P/E ratio is -3.04. In terms of profitability, GEHCV's ROE is +0.19%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, GEHCV is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
GEHCV vs SLGCW Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, GEHCV's ROE is +0.19%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, GEHCV is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
GEHCV vs TBRG Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas TBRG's P/E ratio is 9.37. In terms of profitability, GEHCV's ROE is +0.19%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, GEHCV is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check TBRG's competition here
So-Young International Inc. (NASDAQ: SY)
GEHCV vs SY Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SY has a market cap of 381.8M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SY trades at $2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SY's P/E ratio is -8.82. In terms of profitability, GEHCV's ROE is +0.19%, compared to SY's ROE of -0.16%. Regarding short-term risk, GEHCV is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check SY's competition here
MultiPlan Corporation (NYSE: MPLN)
GEHCV vs MPLN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas MPLN's P/E ratio is -0.23. In terms of profitability, GEHCV's ROE is +0.19%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, GEHCV is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check MPLN's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
GEHCV vs TRHC Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas TRHC's P/E ratio is -4.27. In terms of profitability, GEHCV's ROE is +0.19%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, GEHCV is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
GEHCV vs SMFR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SMFR's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, GEHCV is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
GEHCV vs SPOK Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SPOK has a market cap of 219.5M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SPOK trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SPOK's P/E ratio is 17.52. In terms of profitability, GEHCV's ROE is +0.19%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, GEHCV is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
GEHCV vs AMWL Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, AMWL has a market cap of 203.9M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while AMWL trades at $11.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas AMWL's P/E ratio is -2.71. In terms of profitability, GEHCV's ROE is +0.19%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, GEHCV is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check AMWL's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
GEHCV vs LFMDP Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, LFMDP has a market cap of 158.7M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while LFMDP trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas LFMDP's P/E ratio is -717.41. In terms of profitability, GEHCV's ROE is +0.19%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, GEHCV is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check LFMDP's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
GEHCV vs OPRX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, OPRX has a market cap of 149.7M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while OPRX trades at $7.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas OPRX's P/E ratio is 7.32. In terms of profitability, GEHCV's ROE is +0.19%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, GEHCV is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check OPRX's competition here
LifeMD, Inc. (NASDAQ: LFMD)
GEHCV vs LFMD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, LFMD has a market cap of 149.4M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while LFMD trades at $3.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas LFMD's P/E ratio is -6.18. In terms of profitability, GEHCV's ROE is +0.19%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, GEHCV is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check LFMD's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
GEHCV vs CPSI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CPSI's P/E ratio is -183.80. In terms of profitability, GEHCV's ROE is +0.19%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, GEHCV is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
GEHCV vs HCAT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, HCAT has a market cap of 121.2M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while HCAT trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas HCAT's P/E ratio is 8.20. In terms of profitability, GEHCV's ROE is +0.19%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, GEHCV is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check HCAT's competition here
Augmedix, Inc. (NASDAQ: AUGX)
GEHCV vs AUGX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas AUGX's P/E ratio is -4.99. In terms of profitability, GEHCV's ROE is +0.19%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, GEHCV is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check AUGX's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
GEHCV vs DH Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, DH has a market cap of 100.2M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while DH trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas DH's P/E ratio is 3.65. In terms of profitability, GEHCV's ROE is +0.19%, compared to DH's ROE of -0.79%. Regarding short-term risk, GEHCV is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check DH's competition here
CareCloud, Inc. (NASDAQ: CCLD)
GEHCV vs CCLD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CCLD has a market cap of 99.9M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CCLD trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CCLD's P/E ratio is 9.04. In terms of profitability, GEHCV's ROE is +0.19%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, GEHCV is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
GEHCV vs WORX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, WORX has a market cap of 88M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas WORX's P/E ratio is -6.40. In terms of profitability, GEHCV's ROE is +0.19%, compared to WORX's ROE of -0.35%. Regarding short-term risk, GEHCV is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check WORX's competition here
Forian Inc. (NASDAQ: FORA)
GEHCV vs FORA Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas FORA's P/E ratio is -24.11. In terms of profitability, GEHCV's ROE is +0.19%, compared to FORA's ROE of -0.17%. Regarding short-term risk, GEHCV is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
GEHCV vs CCLDP Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CCLDP's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, GEHCV is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
GEHCV vs SNCE Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SNCE's P/E ratio is -0.27. In terms of profitability, GEHCV's ROE is +0.19%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, GEHCV is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
GEHCV vs AKLI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas AKLI's P/E ratio is -0.71. In terms of profitability, GEHCV's ROE is +0.19%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, GEHCV is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
GEHCV vs SHLT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SHLT's P/E ratio is -3.87. In terms of profitability, GEHCV's ROE is +0.19%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, GEHCV is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SHLT's competition here
OneMedNet Corporation (NASDAQ: ONMD)
GEHCV vs ONMD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ONMD has a market cap of 33.5M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ONMD trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ONMD's P/E ratio is -3.68. In terms of profitability, GEHCV's ROE is +0.19%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, GEHCV is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check ONMD's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
GEHCV vs SHCRW Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, GEHCV's ROE is +0.19%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, GEHCV is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
GEHCV vs ONMDW Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ONMDW has a market cap of 31.1M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ONMDW's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, GEHCV is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
GEHCV vs STRM Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas STRM's P/E ratio is -2.40. In terms of profitability, GEHCV's ROE is +0.19%, compared to STRM's ROE of -0.65%. Regarding short-term risk, GEHCV is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
GEHCV vs RNLX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas RNLX's P/E ratio is -0.33. In terms of profitability, GEHCV's ROE is +0.19%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, GEHCV is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
GEHCV vs LIFW Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas LIFW's P/E ratio is -0.02. In terms of profitability, GEHCV's ROE is +0.19%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, GEHCV is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check LIFW's competition here
Babylon Holdings Limited (NYSE: BBLN)
GEHCV vs BBLN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas BBLN's P/E ratio is -0.04. In terms of profitability, GEHCV's ROE is +0.19%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, GEHCV is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check BBLN's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
GEHCV vs BFRG Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, BFRG has a market cap of 9.9M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while BFRG trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas BFRG's P/E ratio is -1.16. In terms of profitability, GEHCV's ROE is +0.19%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, GEHCV is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check BFRG's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
GEHCV vs ETAO Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ETAO's P/E ratio is -0.01. In terms of profitability, GEHCV's ROE is +0.19%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, GEHCV is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
GEHCV vs MGRX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, MGRX has a market cap of 6.6M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while MGRX trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas MGRX's P/E ratio is -0.29. In terms of profitability, GEHCV's ROE is +0.19%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, GEHCV is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH-WT)
GEHCV vs UPH-WT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, GEHCV is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
GEHCV vs UPH Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas UPH's P/E ratio is -0.07. In terms of profitability, GEHCV's ROE is +0.19%, compared to UPH's ROE of -1.05%. Regarding short-term risk, GEHCV is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check UPH's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
GEHCV vs PEAR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas PEAR's P/E ratio is -0.08. In terms of profitability, GEHCV's ROE is +0.19%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, GEHCV is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
GEHCV vs PEARW Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas PEARW's P/E ratio is -0.00. In terms of profitability, GEHCV's ROE is +0.19%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, GEHCV is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
GEHCV vs OTRK Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas OTRK's P/E ratio is -0.02. In terms of profitability, GEHCV's ROE is +0.19%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, GEHCV is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
GEHCV vs CMAX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CMAX's P/E ratio is -0.00. In terms of profitability, GEHCV's ROE is +0.19%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, GEHCV is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CMAX's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
GEHCV vs BFRGW Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, BFRGW has a market cap of 1.4M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while BFRGW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas BFRGW's P/E ratio is -0.92. In terms of profitability, GEHCV's ROE is +0.19%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, GEHCV is more volatile compared to BFRGW. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check BFRGW's competition here
Aclarion, Inc. (NASDAQ: ACON)
GEHCV vs ACON Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ACON trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ACON's P/E ratio is -0.26. In terms of profitability, GEHCV's ROE is +0.19%, compared to ACON's ROE of -0.59%. Regarding short-term risk, GEHCV is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
GEHCV vs LIFWZ Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, GEHCV is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check LIFWZ's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
GEHCV vs HCTI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, HCTI has a market cap of 953.2K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while HCTI trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas HCTI's P/E ratio is -0.10. In terms of profitability, GEHCV's ROE is +0.19%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, GEHCV is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check HCTI's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
GEHCV vs VSEEW Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, GEHCV's ROE is +0.19%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, GEHCV is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
GEHCV vs MSPRZ Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, GEHCV is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check MSPRZ's competition here
VSee Health, Inc. (NASDAQ: VSEE)
GEHCV vs VSEE Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, VSEE has a market cap of 244K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while VSEE trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas VSEE's P/E ratio is -0.03. In terms of profitability, GEHCV's ROE is +0.19%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, GEHCV is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check VSEE's competition here
Akerna Corp. (NASDAQ: KERNW)
GEHCV vs KERNW Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas KERNW's P/E ratio is -0.00. In terms of profitability, GEHCV's ROE is +0.19%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, GEHCV is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
GEHCV vs KERN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas KERN's P/E ratio is -0.01. In terms of profitability, GEHCV's ROE is +0.19%, compared to KERN's ROE of -0.20%. Regarding short-term risk, GEHCV is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
GEHCV vs LIFWW Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas LIFWW's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, GEHCV is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
GEHCV vs CMAXW Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CMAXW's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, GEHCV is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
GEHCV vs ZCMD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ZCMD has a market cap of 30.5K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ZCMD trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, GEHCV's ROE is +0.19%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, GEHCV is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
GEHCV vs ACONW Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ACONW has a market cap of 13.5K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ACONW's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, GEHCV is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check ACONW's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
GEHCV vs IMS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, IMS has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas IMS's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to IMS's ROE of +0.27%. Regarding short-term risk, GEHCV is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check IMS's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
GEHCV vs SMFRW Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SMFRW's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, GEHCV is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check SMFRW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
GEHCV vs MSPRV Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas MSPRV's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to MSPRV's ROE of N/A. Regarding short-term risk, GEHCV is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check MSPRV's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
GEHCV vs CHNGU Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CHNGU's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, GEHCV is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CHNGU's competition here
CareCloud, Inc. (NASDAQ: MTBC)
GEHCV vs MTBC Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas MTBC's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, GEHCV is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check MTBC's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
GEHCV vs AFFX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, AFFX has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas AFFX's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, GEHCV is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check AFFX's competition here
Castlight Health, Inc. (NYSE: CSLT)
GEHCV vs CSLT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CSLT's P/E ratio is -37.27. In terms of profitability, GEHCV's ROE is +0.19%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, GEHCV is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CSLT's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
GEHCV vs CNVY Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CNVY's P/E ratio is -71.50. In terms of profitability, GEHCV's ROE is +0.19%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, GEHCV is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CNVY's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
GEHCV vs MTBCP Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas MTBCP's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, GEHCV is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check MTBCP's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
GEHCV vs NAVA Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, NAVA has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas NAVA's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, GEHCV is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for GEHCV.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
GEHCV vs CERN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CERN has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CERN's P/E ratio is 55.84. In terms of profitability, GEHCV's ROE is +0.19%, compared to CERN's ROE of +0.14%. Regarding short-term risk, GEHCV is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CERN's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
GEHCV vs CHNG Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CHNG's P/E ratio is -152.72. In terms of profitability, GEHCV's ROE is +0.19%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, GEHCV is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CHNG's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
GEHCV vs MTBCO Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas MTBCO's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, GEHCV is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check MTBCO's competition here
NantHealth, Inc. (NASDAQ: NH)
GEHCV vs NH Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, NH has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas NH's P/E ratio is -0.12. In terms of profitability, GEHCV's ROE is +0.19%, compared to NH's ROE of +0.35%. Regarding short-term risk, GEHCV is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check NH's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
GEHCV vs KURIU Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, KURIU has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas KURIU's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, GEHCV is more volatile compared to KURIU. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check KURIU's competition here